Inhibrx (INBX) Stock Chart & Stock Price History → get a piece of the profit from this land (From True Market Insiders) (Ad) Free INBX Stock Alerts $34.70 +0.21 (+0.61%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Inhibrx Stock Price Performance5 Day Performance+1.64%1 Month Performance+1.11%3 Month Performance-7.91%6 Month Performance+55.68%Year-To-Date Performance-8.68%1 Year Performance+37.92% Receive INBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. INBX Stock Chart for Sunday, May, 19, 2024 INBX Chart by TradingView Inhibrx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$34.49$34.70+0.61%$34.73$34.52967,226 shs$1.82 billion05/16/2024$34.37$34.49+0.35%$34.69$34.37655,196 shs$1.81 billion05/15/2024$34.14$34.37+0.67%$34.37$34.101.81 million shs$1.80 billion05/14/2024$34.05$34.14+0.26%$34.38$34.09324,764 shs$1.79 billion05/13/2024$34.29$34.05-0.70%$34.43$33.951.26 million shs$1.78 billion05/10/2024$34.69$34.29-1.15%$34.75$33.95506,507 shs$1.79 billion Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$34.44$34.69+0.73%$34.75$34.301.12 million shs$1.81 billion05/08/2024$34.39$34.44+0.15%$34.48$34.10307,288 shs$1.80 billion05/07/2024$34.30$34.39+0.26%$34.46$34.23181,625 shs$1.80 billion05/06/2024$34.15$34.30+0.44%$34.35$34.11342,571 shs$1.79 billion05/03/2024$34.01$34.15+0.41%$34.45$33.88246,595 shs$1.79 billion05/02/2024$34.30$34.01-0.85%$34.44$33.91240,639 shs$1.78 billion05/01/2024$34.04$34.30+0.76%$34.58$34.00688,878 shs$1.79 billion04/30/2024$34.16$34.04-0.35%$34.47$34.00200,339 shs$1.61 billion04/29/2024$34.06$34.16+0.29%$34.58$33.99239,219 shs$1.62 billion04/26/2024$34.09$34.06-0.09%$34.15$33.73200,367 shs$1.61 billion04/25/2024$34.38$34.09-0.84%$34.22$34.02179,063 shs$1.62 billion04/24/2024$34.13$34.38+0.73%$34.45$34.07218,293 shs$1.63 billion04/23/2024$34.10$34.13+0.09%$34.48$34.06358,342 shs$1.62 billion04/22/2024$34.32$34.10-0.64%$34.40$33.86467,752 shs$1.62 billion04/19/2024$34.45$34.32-0.38%$34.60$34.22253,758 shs$1.63 billion04/18/2024$34.61$34.45-0.46%$34.83$34.45415,786 shs$1.63 billion04/17/2024$34.61$34.61$34.84$34.58416,492 shs$1.64 billion04/16/2024$34.74$34.61-0.37%$34.90$34.59208,953 shs$1.64 billion04/15/2024$34.98$34.74-0.69%$35.02$34.66214,569 shs$1.65 billion04/12/2024$35.02$34.98-0.11%$35.08$34.77326,429 shs$1.66 billion04/11/2024$34.97$35.02+0.14%$35.42$34.92527,258 shs$1.66 billion04/10/2024$34.93$34.97+0.11%$35.13$34.63605,757 shs$1.66 billion04/09/2024$34.70$34.93+0.66%$35.05$34.60263,833 shs$1.66 billion04/08/2024$34.97$34.70-0.77%$35.09$34.501.51 million shs$1.64 billion04/05/2024$34.65$34.97+0.92%$35.03$34.60217,147 shs$1.66 billion04/04/2024$35.08$34.65-1.23%$35.24$34.62399,022 shs$1.64 billion04/03/2024$34.85$35.08+0.66%$35.14$34.53388,374 shs$1.66 billion04/02/2024$34.87$34.85-0.06%$35.03$34.65418,850 shs$1.65 billion04/01/2024$34.96$34.87-0.26%$35.24$34.86321,914 shs$1.65 billion03/29/2024$34.96$34.96$35.25$34.90231,802 shs$1.66 billion03/28/2024$35.15$34.96-0.54%$35.25$34.90231,799 shs$1.66 billion03/27/2024$35.07$35.15+0.23%$35.25$35.00346,322 shs$1.67 billion03/26/2024$34.94$35.07+0.37%$35.40$34.92310,268 shs$1.66 billion03/25/2024$34.89$34.94+0.14%$35.39$34.91349,015 shs$1.66 billionget a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024.03/22/2024$34.97$34.89-0.23%$35.11$34.89323,990 shs$1.65 billion03/21/2024$35.00$34.97-0.09%$35.25$34.90520,906 shs$1.66 billion03/20/2024$34.99$35.00+0.03%$35.20$34.89338,173 shs$1.66 billion03/19/2024$34.94$34.99+0.14%$35.34$34.92261,456 shs$1.66 billion03/18/2024$35.00$34.94-0.17%$35.22$34.90539,707 shs$1.66 billion03/15/2024$34.99$35.00+0.03%$35.18$34.841.62 million shs$1.66 billion03/14/2024$35.35$34.99-1.02%$35.40$34.90509,360 shs$1.66 billion03/13/2024$35.24$35.35+0.31%$35.50$35.20596,959 shs$1.68 billion03/12/2024$35.16$35.24+0.23%$35.33$35.00339,369 shs$1.67 billion03/11/2024$35.54$35.16-1.07%$35.65$35.16280,024 shs$1.67 billion03/08/2024$35.77$35.54-0.64%$35.80$35.36582,644 shs$1.68 billion03/07/2024$35.71$35.77+0.17%$35.90$35.65398,349 shs$1.70 billion03/06/2024$35.58$35.71+0.37%$36.00$35.60749,506 shs$1.69 billion03/05/2024$35.64$35.58-0.17%$35.85$35.08684,036 shs$1.69 billion03/04/2024$36.45$35.64-2.22%$35.70$34.252.33 million shs$1.69 billion03/01/2024$36.63$36.45-0.49%$37.10$36.40341,674 shs$1.72 billion02/29/2024$37.00$36.63-1.00%$37.38$36.50815,953 shs$1.73 billion02/28/2024$39.56$37.00-6.47%$39.27$36.171.26 million shs$1.75 billion02/27/2024$38.69$39.56+2.25%$39.79$38.40502,642 shs$1.87 billion02/26/2024$38.28$38.69+1.07%$38.99$37.90228,329 shs$1.83 billion02/23/2024$38.33$38.28-0.13%$38.56$38.00441,718 shs$1.81 billion02/22/2024$38.28$38.33+0.13%$38.80$38.15229,418 shs$1.81 billion02/21/2024$38.06$38.28+0.58%$38.50$37.83174,146 shs$1.81 billion02/20/2024$37.68$38.06+1.01%$38.10$37.40307,389 shs$1.80 billion02/19/2024$37.68$37.68$38.19$37.58154,300 shs$1.78 billion Related Companies: Fusion Pharmaceuticals Stock Price Chart Beam Therapeutics Stock Price Chart ADMA Biologics Stock Price Chart Ginkgo Bioworks Stock Price Chart Neumora Therapeutics Stock Price Chart Recursion Pharmaceuticals Stock Price Chart Tarsus Pharmaceuticals Stock Price Chart Sana Biotechnology Stock Price Chart 4D Molecular Therapeutics Stock Price Chart Apogee Therapeutics Stock Price Chart Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INBX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.